Jonathan Simon Cebon
University of Siena
1 paper in the Anchorcite directory, published in 2017, cited 5,446 times in total.
ORCID profileResearch topics
- Cancer Immunotherapy and Biomarkers · 1 paper
- Cutaneous Melanoma Detection and Management · 1 paper
- Melanoma and MAPK Pathways · 1 paper
Frequent co-authors
- Jedd D. Wolchok · 1 paper
- Vanna Chiarion‐Sileni · 1 paper
- Rene C. Gonzalez · 1 paper
- Piotr Lukasz Rutkowski · 1 paper
- Jean‐Jacques Grob · 1 paper
- Charles Lance Cowey · 1 paper
- Christopher D. Lao · 1 paper
- John Wagstaff · 1 paper
Papers
- Overall Survival with Combined Nivolumab and Ipilimumab in Advanced MelanomaNew England Journal of Medicine · 2017 · 5,446 citations
BACKGROUND: Nivolumab combined with ipilimumab resulted in longer progression-free survival and a higher objective response rate than ipilimumab alone in a phase 3 trial involving patients with advanced melanoma. We now report 3-year overall survival outcomes in this trial. METHODS:…
Metadata from OpenAlex (CC0).